Advanced Search

    Technical Analysis for QTRX - Quanterix Corporation

    Grade Last Price % Change Price Change
    D 14.08 1.44% 0.20
    QTRX closed down 2.8 percent on Monday, January 30, 2023, on 80 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Down
    Historical QTRX trend table...
    Date Alert Name Type % Chg
    Fell Below 200 DMA Bearish 1.44%
    MACD Bearish Signal Line Cross Bearish 1.44%
    20 DMA Support Bullish 1.44%
    NR7 Range Contraction 1.44%
    NR7-2 Range Contraction 1.44%
    Narrow Range Bar Range Contraction 1.44%
    Down 3 Days in a Row Weakness 1.44%
    Gapped Down Weakness 1.44%
    200 DMA Support Bullish -1.40%
    NR7 Range Contraction -1.40%
    Older End-of-Day Signals for QTRX ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    200 DMA Resistance about 3 hours ago
    10 DMA Resistance about 3 hours ago
    Rose Above Previous Day's High about 3 hours ago
    Rose Above 200 DMA about 3 hours ago
    Up 3% about 3 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators Basic chart:

    Profile

    Quanterix is a company digitizing biomarker analysis with the goal of advancing the science of precision health. The company’s digital health solution, Simoa, has the potential to change the way in which healthcare is provided today by giving researchers the ability to closely examine the continuum from health to disease. Quanterix’ technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come. The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Biology Disease Infectious Diseases Inflammation Biomarkers Urology Cardiology Neurology Quality Of Life Digital Health

    Is QTRX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jan 20 Bullish Quanterix Corporation (NASDAQ:QTRX) insiders filled their treasuries with US$5.6m worth of stock over last year
    Jan 9 Quanterix Announces Appointment of Brian Blaser to Board of Directors
    Jan 9 Quanterix Expands Laboratory Developed Test Menu with Launch of Neurofilament Light Chain Test
    Jan 3 Quanterix to Present at 41st Annual J.P. Morgan Healthcare Conference
    Dec 5 Quanterix’s Simoa® Technology Drives Advances in Alzheimer’s Disease Research Presented at 2022 Clinical Trials on Alzheimer’s Disease (CTAD) Conference
    Nov 16 Quanterix to Participate in the 15th Clinical Trials on Alzheimer’s Disease (CTAD) Task Force
    Nov 10 Quanterix to Participate in the Canaccord MedTech, Diagnostics and Digital Health & Services Forum
    Nov 10 Quanterix Third Quarter 2022 Earnings: Revenues Beat Expectations, EPS Lags
    Nov 9 Quanterix rises as Q3 results indicate sequential progress
    Nov 9 Quanterix Corporation (QTRX) Q3 2022 Earnings Call Transcript
    See more QTRX news...

    Indicators

    Indicator Value
    52 Week High 35.98
    52 Week Low 6.31
    Average Volume 288,759
    200-Day Moving Average 14.19
    50-Day Moving Average 13.17
    20-Day Moving Average 13.76
    10-Day Moving Average 14.31
    Average True Range 0.87
    RSI 51.92
    ADX 29.01
    +DI 27.31
    -DI 14.11
    Chandelier Exit (Long, 3 ATRs) 12.94
    Chandelier Exit (Short, 3 ATRs) 14.76
    Upper Bollinger Bands 15.10
    Lower Bollinger Band 12.42
    Percent B (%b) 0.54
    BandWidth 19.48
    MACD Line 0.38
    MACD Signal Line 0.39
    MACD Histogram -0.0104
    Fundamentals Value
    Market Cap 439.55 Million
    Num Shares 31.7 Million
    EPS -1.64
    Price-to-Earnings (P/E) Ratio -8.44
    Price-to-Sales 16.39
    Price-to-Book 6.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 14.51
    Resistance 3 (R3) 14.54 14.36 14.41
    Resistance 2 (R2) 14.36 14.20 14.35 14.37
    Resistance 1 (R1) 14.12 14.10 14.03 14.09 14.33
    Pivot Point 13.94 13.94 13.90 13.93 13.94
    Support 1 (S1) 13.70 13.78 13.61 13.67 13.43
    Support 2 (S2) 13.52 13.68 13.51 13.39
    Support 3 (S3) 13.28 13.52 13.36
    Support 4 (S4) 13.25